Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metronomic Vinorelbine in Patients With Metastatic Tumors: Phase II Translational Study

NCT00278070 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT00278070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metronomic Vinorelbine in Patients With Metastatic Tumors: Phase II Translational Study
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
February 29, 2008
Enrollment
Not reported
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, non small cell lung cancer, prostate cancer